- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02854878
Treatment of Head Lice Infestation Using Novel Ultrasonic Comb
March 27, 2019 updated by: ParaSonic Ltd.
A pilot study to evaluate safety and efficacy of the Lucy combined with LucyGel in killing head lice and their eggs.
23 participants will be enrolled in this study. The first 12 will be combed with model A and the remaining 11 will be combed with model B
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
23
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Herzliya, Israel
- Herzeliya medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Males and Females
- Age 6 years and older at the time of enrollment
- Must have an active head lice infestation of at least 10live head lice (found within 5 minutes of mechanic search).
- Hair must be at least 3 cm long.
- Written informed consent - by patient (if over 18 years of age), or by a parent (if patient is under 18 years of age).
- For females of childbearing potential, a statement declaring that she is not currently pregnant.
Exclusion Criteria:
- Used any chemical head lice treatment in the 7 days preceding the trial treatment
- Used antibiotics in the week preceding treatment
- Open wounds in the treatment area
- Skin irritation in the treatment area
- Individuals with skin/scalp condition at the treatment site which, in the opinion of the investigator, will interfere with treatment or evaluation
- Known allergies to any of the gel's components
- Participant that is already enrolled in another study
- Participant who can't be combed with fine Comb dense ASSY2000
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: treatment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adverse events of the device and treatment
Time Frame: up to three days
|
measured by AE
|
up to three days
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Mortality of up to 70% of the mature head lice 3 hours post treatment
Time Frame: 3 hours post treatment
|
3 hours post treatment
|
|
Mortality of up to 50% of the head lice eggs 14 days post treatment.
Time Frame: 14 days post treatment
|
14 days post treatment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 28, 2016
Primary Completion (Actual)
July 26, 2018
Study Completion (Actual)
July 26, 2018
Study Registration Dates
First Submitted
July 26, 2016
First Submitted That Met QC Criteria
July 31, 2016
First Posted (Estimate)
August 4, 2016
Study Record Updates
Last Update Posted (Actual)
March 29, 2019
Last Update Submitted That Met QC Criteria
March 27, 2019
Last Verified
March 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- CL-001
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pediculus Capitis
-
Piedmont Pharmaceuticals, LLCLice Solutions Resource Network (LSRN) ResearchCompletedPediculus CapitisUnited States
-
ParaPRO LLCCompletedPediculus Capitis InfestationUnited States
-
Indonesia UniversityCompletedPruritus | Pediculus CapitisIndonesia
-
Topaz Pharmaceuticals IncCompletedPediculus Humanus Capitis (Head Lice)United States
-
Boston Scientific CorporationCompletedHead Lice | Pediculus Humanus CapitisUnited States
-
Phramongkutklao College of Medicine and HospitalActive, not recruitingIvermectin | School-age Children | Pediculus Capitis Infestation | Permethrin Adverse Reaction | Dimethicone Adverse Reaction | Permethrin Allergy | Dimethicone AllergyThailand
-
Alexandria UniversityRecruiting
-
National institute of SiddhaCompletedTinea Infections Such as Tinea Corporis, Tinea Cruris, Tinea Pedis, Tinea Mannum, Tinea Barbae, Tinea Capitis Are StudiedIndia
-
Sohag UniversityActive, not recruiting
-
PfizerCompleted
Clinical Trials on The Lucy ultrasonic comb models A and B combined with the LucyGel
-
Assistance Publique - Hôpitaux de ParisThe Paul Bennetot Foundation; URC Necker Cochin, FranceCompletedModerate to Severe DementiaFrance
-
Sohag UniversityNot yet recruitingLiver Transplant Disorder | Trauma Abdomen | Liver Resection | Liver Tumours
-
University Hospital, Clermont-FerrandUnknownPostpartum Depression | Postpartum Hemorrhage | Postpartum Women | Postpartum Stress | Postpartum AnxietyFrance
-
Hellenic Mediterranean UniversityUniversity General Hospital of HeraklionNot yet recruiting
-
Universitat Jaume IRecruitingProlonged Grief Disorder (PGD)Spain
-
Huashan HospitalEnrolling by invitationAntifungal Agents | Cryptococcal MeningitisChina
-
Hebei Medical UniversityNot yet recruitingGastric Cancer Patients Undergoing Minimally Invasive Gastrectomy
-
Krishnadevaraya College of Dental Sciences & HospitalCompletedGingival Recession, LocalizedIndia
-
Augusta UniversityActive, not recruitingCovid19United States
-
Medical College of WisconsinActive, not recruitingHemophilia AUnited States